March 2022 – Policy & Medicine

FDA Issues New Set of Guidances Focused on Generic Drug Submissions and Labeling Updates

FDA-Duke to Host Public Workshop Focused on Key Competencies for Opioid Prescriber Education

OPDP Issued Six Letters in 2021

Califf Narrowly Voted by Senate to Be Next FDA Commissioner

CME-MOC Webinar Series to Update Clinicians on Latest in NASH (non-alcoholic steatohepatitis) Diagnosis and Management

Michigan Makes Changes to Laws Surrounding Pharmacy Benefit Managers

Teva Reaches $225 Million Settlement with Texas Over Opioid Claims

Pharmacists’ Role to Expand Over the Next Decade

MedPAC Presents MA Findings, Including Increased Spending

Ten Individual Indicted in $300 Million Healthcare Fraud